Transrectal cytological aspiration biopsy in prostatic disease

Area of Science:

• Urology
• Oncology
• Diagnostic Cytopathology

Background:

• Prostate cancer diagnosis relies on various methods, including physical examination, biochemical markers, and tissue sampling.
• Fine-needle aspiration (FNA) is a minimally invasive technique used for obtaining tissue samples.

Purpose of the Study:

• To evaluate the diagnostic accuracy and utility of the Franzén fine-needle biopsy method for prostate cancer.
• To determine the effectiveness of this method in different clinical scenarios.

Main Methods:

• Analysis of 761 fine-needle biopsy specimens from the prostate using the Franzén method.
• Correlation of cytological findings with histological diagnoses and prostatic phosphatase levels.
• Assessment of diagnostic yield in palpable versus non-palpable cancers.

Main Results:

• The Franzén method diagnosed 83% of palpable prostate cancers with no false negatives.
• No cancers were detected by cytology in cases with benign findings and normal phosphatase levels.
• The method is not effective for screening but aids in confirming diagnoses.

Conclusions:

• The Franzén fine-needle biopsy is valuable for confirming suspected prostate cancer in conjunction with clinical and biochemical findings.
• Repeated biopsies are advised if initial results are negative but suspicion remains high.
• This method is not recommended as a primary screening tool for prostate cancer.